Mycophenolate mofetil: An open-label study in 42 MS patients

被引：0
|
作者：
Vukusic, S. [1 ]
Ducray, F. [1 ]
Gignoux, L. [1 ]
Durand-Dubief, F. [1 ]
Achiti, I. [1 ]
Blanc, S. [1 ]
Confavreux, C. [1 ]
机构：
[1] Hop Neurol & Neurochirurg P Wertheimer, Dept Neurol A, Lyon, France
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [21] Everolimus Versus Mycophenolate Mofetil De Novo After Lung Transplantation: A Prospective, Randomized, Open-Label Trial
    Strueber, M.
    Warnecke, G.
    Fuge, J.
    Simon, A. R.
    Zhang, R.
    Welte, T.
    Haverich, A.
    Gottlieb, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (11) : 3171 - 3180
  • [22] Failure of ondansetron in treating cerebellar tremor in MS patients - an open-label pilot study
    Gbadamosi, J
    Buhmann, C
    Moench, A
    Heesen, C
    ACTA NEUROLOGICA SCANDINAVICA, 2001, 104 (05): : 308 - 311
  • [23] Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial
    Sinha, Aditi
    Puraswani, Mamta
    Kalaivani, Mani
    Goyal, Pragya
    Hari, Pankaj
    Bagga, Arvind
    KIDNEY INTERNATIONAL, 2019, 95 (01) : 210 - 218
  • [24] Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open-Label, Randomized, Bayesian Noninferiority Trial
    Brogan, Paul A.
    Arch, Barbara
    Hickey, Helen
    Anton, Jordi
    Iglesias, Este
    Baildam, Eileen
    Mahmood, Kamran
    Cleary, Gavin
    Moraitis, Elena
    Papadopoulou, Charalampia
    Beresford, Michael W.
    Riley, Phil
    Demir, Selcan
    Ozen, Seza
    Culeddu, Giovanna
    Hughes, Dyfrig A.
    Dolezalova, Pavla
    Hampson, Lisa, V
    Whitehead, John
    Jayne, David
    Ruperto, Nicola
    Eleftheriou, Despina
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (09) : 1673 - 1682
  • [25] Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study
    Manger, Bernhard
    Hiepe, Falk
    Schneider, Matthias
    Worm, Margitta
    Wimmer, Peter
    Paulus, Eva-Maria
    Schwarting, Andreas
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2015, 8 : 205 - 213
  • [26] A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy
    Han, Sang Youb
    Jung, Chan-Young
    Lee, Sang Ho
    Lee, Dong Won
    Lee, Sik
    Kim, Chan-Duck
    Choi, Bum Soon
    Kim, Beom Seok
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 (04) : 452 - 461
  • [27] An open-label active controlled study to evaluate the use of cellcept (mycophenolate mofetil) in liver transplant recipients with renal impairment who are currently on tacrolimus.
    Kim-Schluger, L
    Jain, A
    Fernandez-Sloves, M
    Miller, CM
    HEPATOLOGY, 1999, 30 (04) : 183A - 183A
  • [28] Lumateperone 42 mg in an Open-Label Switch Study in Patients with Stable Schizophrenia: Results by Previous Antipsychotic
    Cutler, Andrew J.
    Edwards, John B.
    Durgam, Suresh
    Mo, Yifan
    Acosta, Jazmin
    Davis, Robert E.
    CNS SPECTRUMS, 2023, 28 (02) : 235 - 236
  • [29] SIMVASTATIN IN SYSTEMIC SCLEROSIS PATIENTS - AN OPEN-LABEL STUDY
    Ionitescu, S. C.
    Mihai, C.
    Bojinca, M.
    Sfrent-Cornateanu, R.
    Ion, A.
    Macovei, L.
    Manea, O.
    Sasu, M.
    Ancuta, I.
    Milicescu, M.
    Mogosan, C.
    Abobului, M.
    Berghea, F.
    Predeteanu, D.
    Ionescu, R.
    Stoica, V.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S158 - S158
  • [30] An open-label pilot study to assess the efficacy and safety of an induction therapy with basiliximab in combination with sirolimus and mycophenolate mofetil in de novo renal allograft recipients.
    Peeters, P
    Van Vlem, B
    Van Holder, R
    Lameire, N
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 189 - 189
12345